Second quarter 2026
Filed Aug 7, 2026RoboShare Introduced Successfully and Designated Top Operating Priority for the Second Half of 2026; Operating Expenses Decline 32% Sequentially
Operating expenses and the net loss declined sequentially, and the Company reported no new shares issued during the quarter and no outstanding indebtedness. However, the Company reported a $4,187,605 net loss, cash and cash equivalents of $577,328, no reported revenue, and commercialization remains dependent on RoboShare pilot execution and revenue-recognition requirements.
Key metrics
as reported| Metric | Value | q/q | y/y |
|---|---|---|---|
| Total operating expensesGAAP | $2,959,325 | declined 32% sequentially | – |
| Sales and marketing expensesGAAP | $85,715 | decreased by 87% | – |
| General and administrative expensesGAAP | $2,868,537 | – | – |
| Credit loss expenseGAAP | zero | – | – |
| Net lossGAAP | $4,187,605 | a sequential decrease | – |
| Non-cash net loss on digital assetsGAAP | $984,364 | – | – |
| Loss on settlement of the Marizyme notesGAAP | $375,844 | – | – |
| Net loss per share, basic and dilutedGAAP | $(0.21) for the quarter | – | – |
| Net loss per share, basic and dilutedGAAP | $(0.73) for the six months | – | – |
| Weighted-average shares outstandingGAAP | 20,286,192 | – | – |
| Weighted-average shares outstandingGAAP | 14,030,150 | – | – |
| Common shares outstandingother | 20,234,993 at June 30, 2026 | unchanged from March 31, 2026 | – |
Third quarter 2026 outlook
- Noteinitial marketplace-facilitated activity targeted to begin in August 2026, with initial revenue anticipated beginning in the third quarter, subject to operational readiness, execution, and applicable revenue-recognition requirements
- Noteanticipates initial revenue generation beginning in the third quarter through Agentir products
Capital returns
- No new shares issued during the second quarter.
- Common shares outstanding of 20,234,993 at June 30, 2026, unchanged from March 31, 2026.
- Shares outstanding increased from 5,160,383 at December 31, 2025, principally through the first-quarter conversion of Series B preferred shares.
What drove it
- RoboShare was introduced at Automate 2026 on June 22, 2026 and was designated the Company’s top operating priority for the second half of 2026.
- The Los Angeles RoboShare pilot is being prepared across local sales, customer service, dispatch, warehouse and delivery logistics, operator training, and standardized operating procedures.
- The asset-light Robot Second Life Cycle model uses previously sold robots and robots supplied by third-party owners as marketplace supply.
- Sales and marketing expense declined as front-loaded brand-launch investment rolled off.
- Cost-normalization measures took effect during the quarter.
- The Company completed the sale of all outstanding loan and creditor interests in all Marizyme promissory notes and approved a structured wind-down of its legacy biotechnology business.
Concerns
- No total revenue was reported for the quarter.
- Initial RoboShare revenue is subject to operational readiness, execution, and applicable revenue-recognition requirements.
- The Company reported a $4,187,605 net loss.
- The loss included a $984,364 non-cash net loss on digital assets attributable entirely to fair-value remeasurement.
- Digital assets are subject to significant market price volatility.
- Cash and cash equivalents were $577,328 as of June 30, 2026.
- The Company stated that its EAI Platform and RWA tokenization work are sequenced behind RoboShare, are moving on longer timelines, and that timelines previously indicated in May should no longer be relied upon.
- The filing directs readers to the Form 10-Q for liquidity, capital resources, and going-concern considerations.
What to watch
- Whether initial marketplace-facilitated activity begins in August 2026.
- Whether RoboShare records initial revenue in the third quarter of 2026.
- Cumulative usage days, repeat-customer activity, per-order economics, and overall operational readiness during approximately the first ninety days of the Los Angeles pilot.
- Decisions on potential expansion to Silicon Valley and New York, which depend on pilot performance, partner readiness, and local market conditions.
- Initial revenue generation through Agentir products beginning in the third quarter.
- Further expense discipline following the decline in sales and marketing spending and cost-normalization measures.
Balance sheet and cash flow
- Cash and cash equivalents of $577,328 as of June 30, 2026, compared to $19,332,707 at December 31, 2025.
- Digital assets with a fair value of $5,212,903, compared to $10,250,497 at December 31, 2025.
- Combined carrying value of approximately $5.8 million.
- Total assets of $7,402,799, compared to $31,279,846 at December 31, 2025.
- Completed its $12.0 million investment in securities of Faraday Future Intelligent Electric Inc. in April 2026.
- Total stockholders’ equity of $5,681,796, compared to $27,950,609 at December 31, 2025.
- Net cash used in operating activities of $7,939,909 for the six months ended June 30, 2026.
- Total current liabilities of $1,721,003, compared to $3,329,237 at December 31, 2025.
- Related-party payables of $237,292, compared to $1,648,945 at December 31, 2025.
- No outstanding indebtedness for borrowed money at June 30, 2026.
Analysis
AIxCrypto’s second quarter was centered on moving RoboShare from planning into commercialization preparation. The Company introduced the robot-sharing marketplace on June 22, 2026, designated it as its top operating priority in July, and is preparing a Los Angeles pilot. No revenue was reported for the quarter. Management targets initial marketplace-facilitated activity in August 2026 and anticipates initial revenue beginning in the third quarter, subject to operational readiness, execution, and applicable revenue-recognition requirements. The Company also anticipates initial revenue generation through Agentir products in the third quarter.
The cost base improved sequentially but remained above the prior-year level. Total operating expenses were $2,959,325, declining 32% sequentially from $4,333,721 while increasing from $1,683,747 in the prior-year quarter. Sales and marketing expense fell to $85,715 from $638,222 in the first quarter as front-loaded brand-launch spend rolled off. General and administrative expense was $2,868,537, including approximately $395,000 of non-recurring director resignation fees and increased wages, consulting fees, and legal fees.
The Company reported a GAAP net loss of $4,187,605, lower than $6,079,016 in the first quarter but compared with a net loss attributable to the Company of $1,687,003 in the prior-year quarter. The quarterly loss included a $984,364 non-cash net loss on digital assets from fair-value remeasurement and a $375,844 one-time loss on settlement of the Marizyme notes. The Marizyme note sale eliminated the Company’s remaining Marizyme note exposure, and the Board approved a structured wind-down of the legacy biotechnology business.
Balance-sheet resources changed substantially from year-end. Cash and cash equivalents were $577,328, digital assets had a fair value of $5,212,903, and total assets were $7,402,799 at June 30, 2026. The Company completed a $12.0 million Faraday Future securities investment in April, held through an entrusted investment arrangement and presented as parent company equity held at cost within stockholders’ equity. Net cash used in operating activities was $7,939,909 for the six months ended June 30, 2026. Current liabilities declined to $1,721,003, related-party payables fell to $237,292, and there was no outstanding indebtedness for borrowed money.
Capital allocation emphasized avoiding additional quarterly dilution and prioritizing RoboShare commercialization. No new shares were issued during the second quarter, leaving common shares outstanding at 20,234,993 at June 30, 2026, unchanged from March 31, 2026. The critical next indicators are Los Angeles pilot usage, repeat-customer activity, per-order economics, operational readiness, and whether the Company converts its stated third-quarter revenue expectations into recognized revenue. EAI Platform and RWA tokenization work remain behind RoboShare and are on longer timelines.
Management, verbatim
This quarter, we made a deliberate choice about focus. We launched RoboShare at Automate in June, and in July designated it as the Company’s top operating priority for the second half of 2026, concentrating resources behind what we believe is our nearest path to revenue,
Jerry Wang, Chief Executive Officer
The financial results for the second quarter mirror the operating narrative: progress toward commercialization, a declining cost base, and an unchanged share count,
Jay Sheng, President and Chief Financial Officer
Not in the filing
stated, not guessed- Total revenue
- Revenue prior-year comparison
- Revenue prior-quarter comparison
- Revenue growth rates
- Segment revenue and segment comparisons
- GAAP gross profit
- GAAP gross margin
- GAAP operating income or loss
- GAAP income tax expense or benefit
- GAAP tax rate
- GAAP net income
- Non-GAAP revenue, gross profit, gross margin, operating income, net income, or EPS
- Prior-year and prior-quarter EPS comparisons
- Operating cash flow for the second quarter
- Free cash flow
- Capital expenditures
- Share repurchases
- Dividends
- Formal quantitative revenue, gross-margin, operating-expense, or tax-rate guidance
- Previous-quarter outlook for guidance comparison
AlphaAI analysis generated from the company’s SEC earnings filing (Form 8-K Item 2.02, or Form 6-K for a foreign private issuer). Every figure was cross-checked against the filing text; consensus estimates, price targets and share-price reactions are not shown because they are not in the filing. AI-generated research, not investment advice.